2026· HAFED POLY Journal of Science, Management and Technology· Vol 7, pp. 277-285· 0 citations
TL;DR
This review reveal how integration of omics technologies and systems biology used in peptide-based therapeutic discovery in cancers indicates prognoses and targeted therapies.
Abstract
signatures of cancers. In particular, such analyses have indicated prognoses, as well as targeted therapies. Advances in omics technologies such as genomics, transcriptomics, proteomics and metabolomics have begun to enable personalized medicine at an extraordinarily detailed molecular level. However, each technology individually cannot capture the entire biological complexity of most human diseases. Integration of multiple technologies has emerged as an approach to provide a more comprehensive view of biology and diseases. Biological systems are formed by an interplay of interactions between a variety of biomolecules, such as DNA, RNA, proteins, and metabolites that act at numerous layers. Therapeutic discovery aims at identifying effective agents to treat diseases by targeting specific biomolecules or pathways involved in pathogenesis. This review reveal how integration of omics technologies and systems biology used in peptide-based therapeutic discovery.
The increasing biological complexity and heterogeneity of cancer have driven a shift in oncology drug discovery from single-target approaches toward system-level strategies capable of capturing multilayered disease regulation. Multi-omics technologies, including genomics, transcriptomics, proteomics, metabolomics, epig...
Deval Koshti, N. Khandale, Jignesh Shah et al.· AAPS PharmSciTech· 0 citations
A mechanistic view on the use of multi‐omics strategies for the investigation of NATs‐induced biological effects to analyze the mechanism of action of chemically modified ASOs, siRNAs and mRNA conjugates is offered.
G. K. Bhatti, Anushka Verma, K. Devi et al.· Chemical Biology and Drug De...· 0 citations
Recent advances in multi-omics technologies are summarized and how integrative analyses are reshaping the understanding of AML evolution are discussed, which highlights emerging therapeutic targets identified through multi-omics investigations and examines their translational potential for innovative drug development.
Chao An, Jingxin Zhang· Innovative Medicines & O...· 0 citations
The integration of multi-omics data revealed the activation of compensatory mechanisms aimed at restoring cellular homeostasis, including metabolic rewiring and stress-response pathways, although these responses were insufficient to counteract nanosystem-induced cytotoxicity.
M. P. Buendia-Nacarino, Dominik Bulfon, Nikola Tom et al.· Pharmaceutics· 1 citation
This review aims to comprehensively evaluate the current knowledge on bacteriocins and postbiotic metabolites as anticancer agents, highlighting their sources, structural and functional properties, mechanisms of action, computational-assisted discovery approaches, nanotechnology-based delivery systems, and challenges a...
Radhamanalan Guhanraj· Frontiers in Oncology· 0 citations
The evolving role of TDP in biomedical research is reviewed, highlighting studies that revealed proteoform-level alterations, identified candidate biomarkers, and advanced the understanding of the roles of proteoforms in human diseases.
Holden T. Rogers, Zachery R. Gregorich, Megan S. Gant et al.· Mass spectrometry reviews (P...· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
